XML 37 R23.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Restructuring and Related Charges | 12 Months Ended
--- | ---
Dec. 31, 2023
Restructuring and Related Activities [Abstract] |
Restructuring and Related Charges | 14. Restructuring and Related Charges Beginning with the appointment of the Company’s new management team in April 2022 and as further announced in August 2022, the Company has implemented a restructuring plan, including a reduction in force, to improve operational efficiency, achieve cost savings and align the Company’s workforce to the future needs of the business. In addition to the reduction in force, the Company is reducing leased office space, optimizing its manufacturing footprint and streamlining support functions. The Company is developing a more disciplined cost management culture throughout its organization by investing in training and advanced information systems. The Company records restructuring and related charges as incurred. These items are classified within restructuring and related charges in the consolidated statements of operations for the year ended December 31, 2023, and primarily include severance costs as well as facility costs (net of sublease income) for leased space in South San Francisco that the Company has vacated as part of the restructuring plan. The Company recognized restructuring and related charges of $7.1 million and $9.7 million for the years ended December 31, 2023 and 2022, respectively. The Company expects to relieve the majority of the existing liability for restructuring charges primarily related to employee severance in 2024. Ongoing restructuring charges will continue to be incurred for facility related costs through the termination of the facility leases. These estimates are subject to a number of assumptions, and actual results may differ. The following table summarizes the change in the Company’s restructuring and other related liabilities for the years ended December 31, 2023 and 2022 (in thousands):
|  | Severance and other employee- related benefits(1) |  |  | Facility Costs |  |  | Other(2) |  |  | Total |
Balance at December 31, 2021 |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Restructuring and related charges |  |  | 5,849 |  |  |  | 2,885 |  |  |  | 998 |  |  |  | 9,732 |
Cash payments |  |  | (1,835 | ) |  |  | (2,885 | ) |  |  | (979 | ) |  |  | (5,699 | )
Balance at December 31, 2022 |  | $ | 4,014 |  |  | $ | — |  |  | $ | 19 |  |  | $ | 4,033 |
Restructuring and related charges |  |  | 2,379 |  |  |  | 4,160 |  |  |  | 537 |  |  |  | 7,076 |
Cash payments |  |  | (5,568 | ) |  |  | (4,160 | ) |  |  | (556 | ) |  |  | (10,284 | )
Balance at December 31, 2023 |  | $ | 825 |  |  | $ | — |  |  | $ | — |  |  | $ | 825 |
(1) Restructuring liabilities are recorded in accrued compensation and related benefits on the consolidated balance sheets. (2) Other restructuring liabilities are comprised mainly of sublease commissions and are recorded in other accrued liabilities on the consolidated balance sheets. The Company’s restructuring and related charges by segment and corporate were as follows (in thousands):
|  | Year Ended December 31, |
|  | 2023 |  |  | 2022 |
Restructuring: |  |  |  |  |  |
Proteomics |  | $ | 1,010 |  |  | $ | 1,363 |
Genomics |  |  | 714 |  |  |  | 1,273 |
Corporate expenses |  |  | 5,352 |  |  |  | 7,096 |
Total restructuring and related charges |  | $ | 7,076 |  |  | $ | 9,732 |

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//420/tableOfContent Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(e)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2 + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration